William S. Kloetzer
About
In The Last Decade
William S. Kloetzer
20 papers receiving 904 citations
Peers
Comparison fields: 5 of 63
- Hematology 440
- Molecular Biology 337
- Genetics 313
- Oncology 208
- Public Health, Environmental and Occupational Health 167
Countries citing papers authored by William S. Kloetzer
This map shows the geographic impact of William S. Kloetzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Kloetzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Kloetzer more than expected).
Fields of papers citing papers by William S. Kloetzer
This network shows the impact of papers produced by William S. Kloetzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Kloetzer. The network helps show where William S. Kloetzer may publish in the future.
Co-authorship network of co-authors of William S. Kloetzer
This figure shows the co-authorship network connecting the top 25 collaborators of William S. Kloetzer. A scholar is included among the top collaborators of William S. Kloetzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Kloetzer. William S. Kloetzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 41 | |
| 3 | 22 | |
| 4 | 9 | |
| 5 | Differential effects of tumor promoters on P210bcr-abl expression. | 4 |
| 6 | Characterization of bcr gene products in hematopoietic cells. | 35 |
| 7 | A novel 53 kDa protein complexed with P210bcr-abl in human chronic myelogenous leukemia cells. | 8 |
| 8 | 44 | |
| 9 | 3 | |
| 10 | Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. | 46 |
| 11 | 240 | |
| 12 | 33 | |
| 13 | 165 | |
| 14 | 159 | |
| 15 | 44 | |
| 16 | 17 | |
| 17 | 9 | |
| 18 | 71 | |
| 19 | 5 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.